financetom
Business
financetom
/
Business
/
NVR Board Approves $750 Million Share Repurchase Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NVR Board Approves $750 Million Share Repurchase Program
Dec 11, 2024 1:18 PM

03:47 PM EST, 12/11/2024 (MT Newswires) -- NVR's (NVR) board approved a stock repurchase program for up to $750 million.

The authorization, with no expiration date, allows purchases to occur periodically in the open market or through privately negotiated transactions based on market conditions, the company said Wednesday in a statement.

Price: 8875.00, Change: +17.38, Percent Change: +0.20

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Merck Nears $1.3 Billion Deal For Eye-Drug Company Eyebio - WSJ
BRIEF-Merck Nears $1.3 Billion Deal For Eye-Drug Company Eyebio - WSJ
May 28, 2024
May 28 (Reuters) - Merck & Co Inc ( MRK ): * MERCK NEARS $1.3 BILLION DEAL FOR EYE-DRUG COMPANY EYEBIO - WSJ * MERCK COULD MAKE AN ADDITIONAL $1.7 BILLION IN MILESTONE PAYMENTS FOR EYEBIO- WSJ Source text: https://tinyurl.com/4rzxz37e Further company coverage: ...
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
May 28, 2024
(Reuters) - Merck & Co ( MRK ) is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the Wall Street Journal reported on Tuesday. (Reporting by Kanjyik Ghosh; Editing by Subhranshu Sahu) ...
Merck nears $1.3 bln cash deal for eye-drug company EyeBio, WSJ reports
Merck nears $1.3 bln cash deal for eye-drug company EyeBio, WSJ reports
May 28, 2024
May 28 (Reuters) - Merck & Co ( MRK ) is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the Wall Street Journal reported on Tuesday. (Reporting by Kanjyik Ghosh; Editing by Subhranshu Sahu) ...
Brazil's Congress advances bill to tax low-cost online orders
Brazil's Congress advances bill to tax low-cost online orders
May 28, 2024
BRASILIA, May 28 (Reuters) - Brazil's lower house of Congress approved on Tuesday the main text of a bill that would enact a new 20% import tax on international online purchases under $50, significantly down from a higher tax rate that was originally proposed. The bill must still be voted on by the Senate. The new import tax rate for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved